North America Egg Donation Market size exceeded USD 450 million in 2020 and is anticipated to witness 13.3% CAGR from 2021 to 2027.
Growing incidence of infertility in North America will drive the regional demand for assisted reproductive technologies (ART). The prevalence of infertility is attributed to reproductive abnormalities such as poor ovarian reserve, fallopian tubes deficiency, poor oocyte quality and embryo quality. In addition, demographic shift with increasing working women population has resulted in delayed pregnancy. As age is one of the major factors impacting childbearing, delayed pregnancies have led to insufficiency in carrying child.
Get more details on this report - Request Free Sample PDF
Growing awareness regarding fertility treatments and increasing medical tourism with favourable regulatory scenario in the region will benefit the industry penetration. Further, focus on infrastructure development with adoption of advanced technologies has enabled service providers to attract patients from other regions. Moreover, high success rate associated with ART treatments and its expanding opportunities for homosexual parents will impel the market growth.
COVID-19 pandemic has significantly impacted the number of egg donation cycles during initial period. Procedural deferrals in the initial period affected the revenues of service providers. Additionally, movement restrictions and risk of infection has led to delay in planned cycles during pandemic.
Frozen egg donation segment held more than 35% market share in 2020. Frozen eggs are retrieved by well screened donors and stored to use during ART process. The availability of donors and favourable compensation policy will fuel the segment growth. Further, frozen egg cycle offers advantage of low procedural time and comparatively lower cost. In addition, it provides flexibility of time to initiate cycles with no need for synchronization with recipients.
Fertility clinics segment revenue was over USD 280 million in 2020. Greater availability and accessibility of advanced techniques increases patient’s inclination towards fertility clinics. The collaboration between egg banks has reduced procedural time and enabled these facilities to effectively manage overall process. Furthermore, with increasing funding in developed countries to facilitate network of ART service providers.
The U.S. egg donation market accounted for over 90% revenue share in 2020, attributed to rapid development and adoption of assisted reproductive technologies. Rising awareness regarding ART as well as surge in procedure success rate will boost the industry growth. Moreover, increasing numbers of fertility centers, hospital settings and egg banks across the country will stimulate the market expansion. Additionally, appropriate consultations and availability of highly skilled professionals in service centers will influence the market demand in the U.S.
Eminent players engaged in the market include My Egg Bank, Boston IVF, TRIO Fertility, California fertility partner and Cryobank lifescience among others. These companies are undertaking various strategies to access greater market share through augmentation of service portfolio.